Skip to content

ION Exchange (India) Limited (IONEXCHANG)

Micro Cap

Industrials stocks · Micro cap · NSE

ION Exchange (India) Limited is a global leader in total water and environment management with 62+ years of expertise. Operating in 50+ countries, it provides solutions for process water, wastewater treatment, drinking water, and specialty chemicals to industries, institutions, homes, and communities, supported by world-class manufacturing and R&D.

₹367.9
-9.60 · -2.54%
Market cap ₹5,678 Cr
Data qualityFresh enough for analysisQuote updated 19 Oct, 03:31 pm IST
Details
Quote19 Oct, 03:31 pm IST
Base fundamentals14 Oct 2026 · screener
Latest result06 Aug, 01:49 am IST
Score20 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags02 May 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Industrials P/E 26.2 (n=537)
Technical timing lens

Trend score and candlestick chart

46Neutral

RSI oversold · MACD −

Stock trend: 44
Sector RS: 50
Sector 3M: -6.3% vs Nifty 500 -5.6%

Latest mapped FPI equity flow was not positive. View sector evidence

Technical chart

IONEXCHANGD candles · FIT view-7.4%
Latest close ₹367.90 on 2026-10-19
Bar
-2.5%
RSI
29
MACD hist
-4.61
52W pos
32%
Visible chart range
Candle interval
2026-10-19O ₹377.50H ₹377.50L ₹363.35C ₹367.90Vol 1.6L sh
₹319.37₹363.01₹406.65₹450.29₹493.9452H₹367.902026-06VolRSIMACD2026-042026-062026-082026-092026-11
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context

Relative performance and chart statistics

Adjusted completed-session prices, rebased to 100

IONEXCHANGNifty India ManufacturingNifty 500
-18%-10%-2%+6%20 Jul1 Sept19 Oct19 Oct 2026IONEXCHANG -15.2%Nifty India Manufactu… -5.8%Nifty 500 -5.6%
IONEXCHANG
-15.2%
Nifty 500
-5.6%
Nifty India Manufacturing
-5.8%
Vs Nifty 500
-9.7 pp
Chart stats
19 Oct 2026
From 52W high
-24.3%
₹486
52W range position
32%
₹312.7 - ₹486
ATR (14)
3.8%
₹14.1
Volume vs 20D
0.87x
Latest completed session
Avg traded value
₹6.8 Cr
20-session average
20D price channel
₹363.4 - ₹446.1
21.1% annualized volatility
Research snapshot

What the evidence says now

Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is weak.

Suggested next step
Check latest quarters
Result consistency is weak; verify whether the thesis is improving or deteriorating.
U-Score
Legacy · OVERVALUED
19

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Latest result
Bad
0

Revenue +20.1% · PAT -93.7% YoY

Technical
Neutral
46

Price trend and sector-relative-strength timing.

Valuation
Legacy model
-582.3%

Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.

Trust
Limited evidence
60

Financial-only signal; management claim evidence is not sufficient yet.

Financials

Fundamentals, quarterly history, margins, returns and balance-sheet evidence

Latest result

Quarter ended 30 Jun 2026

Bad · 0/100

PAT -94% YoY · margin compression · Rev +20% YoY

Filed 05 Aug 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹700.5 Cr+20.1%-18.9%
EBITDA₹31.7 Cr-49.2%+60.8%
Operating margin4.5%-619 bps+224 bps
PAT₹3.1 Cr-93.7%-87.4%
PAT margin0.4%-787 bps-237 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Fundamentals

Valuation

P/E
51.60
P/B
4.24
EV/EBITDA
24.54
Market Cap
5678.00Cr

Profitability

ROE
12.00%
ROCE
14.20%
ROA
2.91%
Dividend Y
0.32%

Growth (CAGR)

Revenue 5Y
15.00%
EPS 5Y
1.00%
Revenue 3Y
14.00%
EPS 3Y
-8.00%

Balance Sheet

Debt/Equity
0.36
Interest Coverage
5.97×
Altman Z
3.44
Book Value
91.30

Cash Flow

FCF Yield
—
FCF Positive Y
7/5
OCF
-28.00 Cr
EPS TTM
6.69

Shareholding

Promoter Hold
25.43%
Promoter Pledge
0.00%
Momentum 52W
43%

Financial History

Updated 18/10/2026

Revenue

₹ Cr
Latest: 700-18.9% vs prev
0863.3Sep 2023: 533Dec 2023: 554Mar 2024: 782Jun 2024: 568Sep 2024: 644Dec 2024: 691Mar 2025: 835Jun 2025: 583Sep 2025: 734Dec 2025: 734Mar 2026: 863Jun 2026: 700Q2 23Q3 23FY24Q1 24Q2 24Q3 24FY25Q1 25Q2 25Q3 25FY26Q1 26

Net Profit

₹ Cr
Latest: 3.1-87.4% vs prev
072.5Sep 2023: 42.4Dec 2023: 47.2Mar 2024: 72.5Jun 2024: 44.8Sep 2024: 50.6Dec 2024: 49.6Mar 2025: 63.2Jun 2025: 48.4Sep 2025: 49.9Dec 2025: 20.6Mar 2026: 24.3Jun 2026: 3.1Q2 23Q3 23FY24Q1 24Q2 24Q3 24FY25Q1 25Q2 25Q3 25FY26Q1 26
ROE is shown only in the Annual view — quarterly equity data isn't published.

Technicals

Trend interpretation, Stage 2, relative strength, volume and indicator evidence

Daily technical trend read

Mixed signals

Signals are conflicting — long-term trend down. RSI 29. Wait for confirmation.

  • Price below SMA200 (long-term downtrend) — short-term bounces likely countertrend.
  • SMA20 roughly flat — short-term momentum stalled.
  • RSI(14) at 29 — oversold zone; bounce conditions.
  • MACD below signal, histogram expanding negatively — bearish momentum building.
  • 24% off 52W high · 18% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Nifty 500 leadership

Relative Strength & Trend Stage

49
RS percentile
Stage 1 Base / Transition
1M return
-16.8%
3M return
-15.2%
6M return
-10.2%
1Y return
-6.1%
RS 1D
0
RS 20D
-20
Sector rank
#2
Industry rank
-
Stage evidence
  • Price is within 6.2% of the 30-week proxy.
  • The 30-week proxy changed +1.7% over 20 sessions.
  • The moving-average structure does not confirm Stage 2 or Stage 4.
50-DMA
price below
200-DMA
price below
Sector
leading
Industry
unranked
Relative-strength line vs Nifty 500 (base 100)
262 observations
19 Oct 2026Value 93.26-1.53%
788796105114Sept 25Feb 26Jun 26Oct 2693
RS vs Nifty 50093

Valuation & peers

U-Score 19 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies

19U-SCORE
OVERVALUED

Fundamental score breakdown

U band · OVERVALUED
Valuation0/30
Growth6/25
Quality1/20
Balance Sheet6/15
Cash Flow3/10
Piotroski
5/9 (+3)
Penalties
0
Raw sum
19

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

19/100 · legacy band OVERVALUED

Positive drivers

  • Balance sheet contributes 6/15 to the score.
  • Cash flow contributes 3/10 to the score.
  • Growth contributes 6/25 to the score.

Main drags

  • Fair-value margin of safety is negative at -582.3%.
  • Valuation is weaker at 0/30; verify the latest quarterly trend.
  • Quality is weaker at 1/20; verify the latest quarterly trend.
Sector valuation model

Blended valuation: PE, EV/EBITDA, FCF yield, and balance-sheet checks

For this sector, IndiaPulse uses a blended lens rather than relying on a single valuation ratio.

Blended relative
Primary lens
PE, EV/EBITDA, margin of safety, and FCF yield together.
Secondary checks
ROE/ROCE, growth, cash conversion, leverage, promoter risk.
Main risk check
One cheap metric is not enough if quality or cash flow is weak.
PE
51.6
PB
4.2
EV/EBITDA
24.5
ROE
12.0%
ROCE
14.2%
FCF Yield
—
Debt/Equity
0.4
MoS
-582.3%
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 20 Oct 2026
v4.3-runtime-valuation
Final score
19
Previous: 19
Legacy U-Score band
OVERVALUED
Previous: OVERVALUED
Margin of safety
-582.3%
Previous: -582.3%

Score history

12 stored score snapshots. Latest stored move: +0 points.

20 Oct 2026
v4.3-runtime-valuation
19
19
19
19
19
19
19
19
19
19
19
19

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
₹117.23
-213.8% MoS
Growth-justified P/E
8.1
Growth-justified Value
₹53.92
-582.3% MoS
PEG
51.60

Comparable companies

Peers

Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.

Compare all ↗
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
WABAG
Micro
VA Tech Wabag Limited
Water Treatment
match 39
49
29.6
15.9%
-21%
FAIR VALUE
CEWATER
Small
Concord Enviro Systems Limited
Environmental Services
match 36
27
119.0
4.5%
-155%
OVERVALUED
JASH
Small
Jash Engineering Limited
Industrial Machinery
match 12
43
40.0
16.0%
+0%
WATCHLIST
INDIANHUME
Small
Indian Hume Pipe Company Limited
Building Materials
match 9
50
20.2
4.2%
+35%
FAIR VALUE
DENTA
Small
Denta Water and Infra Solutions Limited
Environmental Services
match 5
64
13.1
13.3%
+68%
UNDERVALUED

Business, management & trust

Growth engines, risks, management commitments and evidence-backed delivery

Business and thesis

Where growth can come from, and what can break the case

Thesis under stressReviewed 2026-10-11T15:17:32.038Z
Management commentary snapshot

IONEXCHANG reported mixed FY2025-26 results. While Treatment Solutions, Lifecycle Services, Specialty Chemicals, and Consumer Products saw revenue growth, EBIT significantly declined in Treatment, Industrial, Specialty, and Consumer segments, with Consumer Products remaining loss-making.

Despite revenue growth in most segments, the widespread decline in EBIT across Treatment Solutions, Industrial Products, Specialty Chemicals, and Consumer Products in FY2025-26 indicates significant pressure on profitability. The persistent losses in the Consumer Products segment are a concern.

Current business mix

Revenue by New Reporting Segment (FY2025-26)

Latest issuer-disclosed distribution across 5 reported categories.

Businessmix
Treatment Solutions36.7%
Industrial Products14.3%
Lifecycle Services9.4%
Specialty Chemicals28.4%
Consumer Products11.2%
Growth engines

Industrial Resins Expansion

5X capacity expansion at Roha, targeting 10% global resin market share from 2.5%.

Pharma Resins Expansion

6X capacity expansion at Ankleshwar, targeting 17% market share from 3.5%.

Membrane Manufacturing

3X business growth by 2024, full capacity utilization, second casting & coating line at Goa.

Lifecycle Services Growth

10% CAGR YoY, 60% growth over five years, 30,000+ customers served.

Capacity and execution

Industrial Resins Facility

Roha facility saw 5X capacity expansion, establishing India's first Non-Solvent Resin manufacturing.

Pharma Resins Facility

Ankleshwar facility expanded 6X, enhancing FDA Approved Manufacturing capacity for pharma resins.

Membrane Manufacturing Lines

Goa facility commissioned a second casting & coating line and indigenous UF hollow fiber membrane manufacturing.

Standard Systems Production

Wada facility now produces 72,000 FRP vessels/year with a dedicated line for Culligan.

Tailwinds

New Energy Solutions

Developing High Purity DM Water Systems for Electrolyzers and containerized Hydrogen Skids.

Semiconductor Solutions

Providing Ultra Pure Water (UPW) systems and advanced membrane systems for the sector.

Data Center Solutions

Offering wastewater reuse, chemical recovery, and cooling water treatment solutions.

Lithium Extraction

Recovering Lithium from battery waste and brines using advanced membrane & resin solutions.

Management accountability

What management said, and what results must prove

Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.

Analyst reading lens
Compare YOY

The financial data is presented on an annual basis (FY2021-22 to FY2025-26), making year-over-year comparison the most appropriate method to assess performance trends and growth.

Sector KPIs management disclosed

Treatment Solutions Revenue

Revenue grew to Rs 1122 Cr in FY2025-26 from Rs 1069 Cr in FY2024-25.

Treatment Solutions EBIT

EBIT declined to Rs 27 Cr in FY2025-26 from Rs 30 Cr in FY2024-25, with a -18% CAGR (FY22-26).

Industrial Products Revenue

Revenue declined to Rs 437 Cr in FY2025-26 from Rs 473 Cr in FY2024-25.

Industrial Products EBIT

EBIT declined to Rs 29 Cr in FY2025-26 from Rs 51 Cr in FY2024-25, with a -1% CAGR (FY22-26).

Management forward view

Vision Statement

To be the leader in our business, vital to people’s lives & the environment.

Industrial Resins Strategy

Expand conventional resin capacity to support future growth and increase global resin market share.

Pharma Resins Strategy

Broaden resin offerings to address domestic and export demand, reducing dependence on outsourced products.

Membrane Platform Development

Building a future-ready membrane platform powered by technology leadership to capture high-growth opportunities.

Thesis monitor

Numbers and claims to verify in the next filings

CheckpointCurrent evidenceWhat to verify next
Industrial Resins Global Market Share2.5%Progress towards 10% target.
Pharma Resins Market Share3.5%Progress towards 17% target.
Membrane Business Growth3X business growth by 2024 (validated)Continued growth and full capacity utilization.
Consumer Products EBITRs -10 Cr (FY2025-26)Improvement towards profitability and CWS margin optimization.

Verification checkpoints are IndiaPulse research interpretation, not investment advice.

Trust Score
60Limited evidence · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Limited evidence: Claim history is still being built. It ranks around the 28th percentile of the scored universe and 24th percentile within Industrials. Main check: financial discipline is weak at 38/100.

This is a financial-behaviour screen, not a claim-tested management reliability verdict.

Computed 05 Sept 2026
management-trust-v1
158 docs text-extracted · 51 concalls text-extracted
Score band
Limited evidence

Financial behaviour is scored, but management claims do not yet have enough outcome checks.

Relative rank
28th percentile

overall median 67 · Industrials: 24th pctile, median 68 · Micro: 15th pctile, median 73

Evidence depth
Financial-only

158 documents have extracted text, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Limited evidence · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Acceptable, but check the weakest sub-score before increasing exposure.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
78
strong · holding, pledge, alignment
Cash flow
52
watch · profit to cash conversion
Balance sheet
89
strong · leverage and solvency
Discipline
38
weak · capital discipline
Results
39
weak · quarterly consistency

Trust positives

  • ▸Promoter pledge is zero.
  • ▸7 years of positive FCF.
  • ▸4/4 latest quarters had positive YoY revenue growth.

Trust risks

  • ▸Operating cash flow is negative at ₹-28 Cr.
  • ▸3 latest quarters had PAT decline worse than 25% YoY.
  • ▸ROCE trend is -6.8%.
  • ▸Revenue CAGR is 14% but EPS CAGR is -8%.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Important announcements & filings

Latest exchange and company disclosures found within the past two years.

7 shown
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 19 Aug - ION Exchange (India) Limited has informed about the copies of Newspaper Publication in respect of Notice for the 62nd Annual General Meeting of the Company.

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 14 Aug - ION Exchange (India) Limited has informed about the copies of Newspaper Publication in respect of the information regarding the 62nd Annual General Meeting of the …

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order 10 Jul - Won USD 52.83 million international filtration supply contract from Hyundai E&C, to execute over 18 months.

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 4 Jun - ION Exchange (India) Limited has informed about Copy of Newspaper Publication

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 28 May - ION Exchange (India) Limited has informed about Copy of Newspaper Publication

Source: Bse

Open source ↗
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.